Hunt Hazel sold CORT
February 9, 2026 · Form 4 insider transaction
Hunt Hazel sold 77,968 shares of Corcept Therapeutics Incorporated at $41.31 per share, a transaction worth $3.22M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
77,968
Price
$41.31
Total value
$3.22M
InsiderHunt Hazel
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after255,437
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 26, 2026.